Elan Again Beats Claims It Hid Drug Trial Data

Law360, New York (October 4, 2011, 7:37 PM EDT) -- For the second time, Elan Corp. PLC on Tuesday dodged a shareholder suit alleging it concealed drug trial information after a federal judge ruled an amended complaint did not properly allege the company intentionally misled investors about the safety and effectiveness of two drugs.

The amended complaint did provide stronger support for allegations of falsity regarding public statements about trials of the Alzheimer's drug Bapineuzumab and the multiple sclerosis drug Tysabri, but U.S. District Judge Charles R. Breyer of the Northern District of California said the...
To view the full article, register now.




Case Information

Case Title

Philco Investments, LTD et al v. Martin et al

Case Number



California Northern

Nature of Suit



Charles R. Breyer

Date Filed

June 23, 2010

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.